Sherbrooke Park Advisers LLC Altimmune, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q3 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 15,904 shares of ALT stock, worth $66,319. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,904Holding current value
$66,319% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
194Shares Held
40.1MCall Options Held
3.82MPut Options Held
2.8M-
Vanguard Group Inc Valley Forge, PA6.37MShares$26.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.32MShares$22.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.6MShares$15 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.13MShares$8.89 Million0.37% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$8.41 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $204M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...